|
|
|
| Clinical effect of Qishen Granules in the treatment of type 2 diabetes mellitus patients with ophthalmoxerosis with deficiency of both qi and yin |
| JU Pin1 ZHAO Lei2 LI Yuexin1 ZUO Tao2 |
1.Graduate School, Liaoning University of Traditional Chinese Medicine, Liaoning Province, Shenyang 110032, China;
2.Department of Ophtalmology, the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Liaoning Province, Shenyang 110034, China |
|
|
|
Abstract Objective To observe the clinical effect of Qishen Granules in the treatment of type 2 diabetes mellitus patients with ophthalmoxerosis with deficiency of both qi and yin. Methods From December 2020 to May 2021, 74 type 2 diabetes mellitus patients with ophthalmoxerosis with deficiency of both qi and yin (148 eyes in total) admitted to the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine were collected and divided into control group and treatment group according to the random number table method, with 37 cases in each group. The control group was given 0.3% Sodium Hyaluronate Eye Drops, and the treatment group was given Qishen Granules orally on this basis. The treatment course was 14 days in both groups. Keratograph 5M ocular surface analyzer was used to measure the relevant indicators before and after treatment, including the non-invasive first tear film break-up time (NIBUTf), non-invasive average tear film break-up time (NIBUTav), lacrimal river height (LTMH), meibomian gland loss score, and ocular surface disease index (OSDI). Results After treatment, the OSDI in the two groups were lower than those before treatment, and the treatment group was lower than the control group, and the differences were statistically significant (P ＜ 0.05). After treatment, NIBUTf and LTMH in the two groups were higher than those before treatment, NIBUTav in the treatment group was higher than that before treatment, and NIBUTf, NIBUTav, and LTMH in the treatment group were higher than those in the control group, and the differences were statistically significant (P ＜ 0.05). After treatment, the meibomian gland loss scores in the treatment group was lower than that before treatment and the control group, and the differences were statistically significant (P ＜ 0.05). Conclusion Qishen Granules can effectively improve the main symptoms of type 2 diabetes mellitus patients with ophthalmoxerosis with deficiency of both qi and yin, and the value of clinical promotion.
|
|
|
|
|
|
[1] Craig JP，Nichols KK，Akpek EK，et al. TFOS DEWS Ⅱ Definition and Classification report [J]. Ocul Surf，2017，15：276e83.
[2] 王一鸥，段国平.2型糖尿病患者不同视网膜病变程度下眼表及角膜病变的临床研究[J].国际眼科杂志，2019，19（1）：104-106.
[3] 黄鑫玲.干眼的中西医治疗新进展[J].中国中医眼科杂志，2020，30（6）：443-446.
[4] 莫守仁，黄祖烽.Keratograph眼表综合分析仪对2型糖尿病患者泪膜功能变化的临床观察[J].锦州医科大学学报，2019，40（1）：60-62.
[5] 蒋鹏飞，彭俊，周亚莎，等.中医药治疗干眼疗效的Meta分析[J].国际眼科杂志，2018，18（6）：1023-1027.
[6] 亚洲干眼协会中国分会，海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组，中国医师协会眼科医师分会眼表与干眼学组.中国干眼专家共识：检查和诊断（2020年）[J].中华眼科杂志，2020，56（10）：741-747.
[7] Schiffman RM，Christianson MD，Jacobsen G，et al. Reliability and validity of the Ocular Surface Disease Index [J]. Arch Ophthalmol，2000，118（5）：615-621.
[8] 世界中医药学会联合会.国际中医临床实践指南 干眼（2021-12-14）[J].世界中医药，2022，17（16）：2235-2239， 2244.
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中国实用内科杂志，2018，38（4）：34-86.
[10] 张帆，马怡娴，赵江月.386例眼科门诊患者睑板腺缺失程度特征分析[J].中国卫生统计，2019，36（3）：425-426.
[11] Cho NH，Shaw JE，Karuranga S，et al. IDF Diabetes Atlas：Global estimates of diabetes prevalence for 2017 and projections for 2045 [J]. Diabetes Res Clin Pract，2018，138：271-281.
[12] 曾孝宇，赵少贞.糖尿病患者泪液及泪膜变化的研究进展[J].眼科新进展，2017，37（11）：1097-1100.
[13] 沈乎醒，高卫萍.2型糖尿病发生干眼的相关因素分析[J].国际眼科杂志 2018，18（1）：126-129.
[14] 李春威，常丹.芪明颗粒联合七叶洋地黄双苷滴眼液治疗2型糖尿病干眼症的临床效果[J].中国当代医药，2021， 28（32）：140-143.
[15] Asghar O，Petropoulos IN，Alam U，et al. Corneal Confocal Microscopy Detects Neuropathy in Subjects With Impaired Glucose Tolerance [J]. Diabetes Care，2014，37（9）：2643- 2646.
[16] Shamsheer RP，Arunachalam C. A Clinical Study of Meibomian Gland Dysfunction in Patients with Diabetes [J]. Middle East Afr J Ophthalmol，2015，22（4）：462-466.
[17] Ding J，Liu Y，Sullivan DA. Effects of Insulin and High Glucose on Human Meibomian Gland Epithelial Cells [J]. Invest Ophthalmol Vis Sci，2015，56（13）：7814-7820.
[18] 姚鹏，杨惠婷，帅天姣.针刺联合中药凉雾熏眼治疗中重度干眼症疗效观察[J].上海针灸杂志，2015，34（12）：1192-1194.
[19] 蔡红莲.疏肝润目汤治疗肝肾阴虚型糖尿病干眼症49例[J].陕西中医，2017，38（9）：1222-1223.
[20] 赵磊，李晓静，王方媛，等.基于气与津液相互关系论干眼[J].中国中医眼科杂志，2020，30（12）：888-890.
[21] 赵磊，迟凯耀，周慧敏，等.眼针疗法治疗“气阴两虚型”干眼的临床研究[J].中华眼视光学与视觉科学杂志，2022，24（4）：309-313.
[22] 洪慧，付智勇，熊世红，等.干眼症的药物疗效比较[J].医学临床研究，2006，23（1）：38-39.
[23] 沈峻.补肾丸合明目五子汤联合玻璃酸钠滴眼液治疗干眼症的效果探讨[J].中国医药科学，2020，10（23）：117- 119，215.
[24] 刘枚芳，练鹏颖，李佩珊，等.杞菊地黄丸联合西药治疗干眼症疗效与安全性Meta分析[J].辽宁中医药大学学报，2017，19（2）：108-111.
[25] 刘芳，邹丹，宋秋颖，等.羧甲基纤维素钠联合杞菊地黄丸治疗白内障术后干眼病患者的临床效果[J].中国医药科学，2020，10（20）：225-227，253.
[26] 宿梦苍，郝晓琳，张仲臣.干眼症眼表损害炎症机制[J].国际眼科杂志，2015，15（5）：821-824.
[27] 张斌，李青松，赵艳青，等.中西医治疗干眼的研究进展[J].中国当代医药，2020，27（6）：26-31.
[28] Abdelfattah NS，Dastiridou A，Sadda SR，et al. Noninvasive Imaging of Tear Film Dynamics in Eyes With Ocular Surface Disease [J]. Cornea，2015，34（S10）：S48.
[29] 袁进，韩雪，丁婧娟，等.干眼患者泪膜破裂形态的临床研究[J].南京医科大学学报（自然科学版），2022，42（8）：1183-1187.
[30] Finis D，Ackermann P，Pischel N，et al. Evaluation of meibomian gland dysfunction and local distribution of meibomian gland atrophy by non- contact infrared meibography [J]. Curr Eye Res，2015，40（10）：982.
[31] 赵磊.干眼的中医证型及杞参方治疗干眼的作用机制研究[D].沈阳：辽宁中医药大学，2021. |
|
|
|
